News & Press

Intellijoint Surgical® chats with MedCity News about the recent 11M funding announcement and future growth.

From inception to commercialization in less than six years, Intellijoint Surgical® is excited to announce the completion of its Series A fundraising round – the biggest milestone to date. Read Full Press Release Press Release;

Intellijoint Surgical CEO, Armen Bakirtzian, discusses the challenges of securing funding as the company advances to the next stage of growth. Read Full Article

July 8, 2016 (Waterloo, Ontario) – Intellijoint Surgical® – a privately held Canadian medical technology company committed to developing and commercializing affordable 3D mini-optical navigation tools – is pleased to announce the first successful clinical use of the Direct Anterior Approach (DAA) Application of intellijoint HIP®.  DAA is a minimally invasive surgical technique that approaches Total Hip Arthroplasty (THA)

Waterloo, Ontario, March 17, 2016 – Intellijoint Surgical Inc., a privately held Canadian medical technology company committed to developing and commercializing miniaturized surgical smart tools announced today the signing of a distribution agreement with Corin Group. The deal gives Corin distribution rights for Intellijoint’s flagship product, intellijoint HIP™, in Australia and paves the way for broader distribution and

Dr. Allan Gross of Mount Sinai Hospital will be discussing his experiences using intellijoint HIP™ at the Intellijoint Surgical Booth (#2115) at the AAOS Annual Meeting – Friday Mar 4th: 2:30 PM – 3:30 PM during Exhibitor Social Hour. Stop by to learn first hand how you can benefit from intellijoint HIP, a miniaturized surgical smart tool for THA. 

intellijoint HIP® used for the first time in the New York region by Dr. Ran Schwarzkopf at NYU Langone’s Hospital for Joint Diseases.